Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 4th, 2023
Crypto Hack Lawsuits Rise as Theft Victims Try Untested Claims
Privacy & Data Security Partner Rick Borden is quoted in the article, “Crypto Hack Lawsuits Rise as Theft Victims Try Untested Claims” published by Bloomberg Law. The article discusses Bloomberg’s analysis of lawsuits against cryptocurrency exchanges, digital wallet providers, and mobile service companies following a high number cyberattacks. In regards to lawsuits targeting companies blocked by mandatory arbitration provisions in plaintiffs’ user agreements; Rick is quoted saying, “Arbitration provisions, which require dispute resolution outside of the judicial system, aren’t necessarily consumer friendly. A losing plaintiff could, for example, end up having to pay the winner’s attorneys’ fees.”
Read the full article here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
